Nebulized formoterol provides added benefits to tiotropium treatment in chronic obstructive pulmonary disease

被引：0
|
作者：
Donald P. Tashkin
Nicola A. Hanania
Joe McGinty
Kimberly Denis-Mize
Imtiaz Chaudry
机构：
[1] David Geffen School of Medicine at UCLA,Division of Pulmonary and Critical Care Medicine
[2] Baylor College of Medicine,Division of Pulmonary and Critical Care Medicine
[3] Dey Pharma LP,undefined
来源：
Advances in Therapy | 2009年 / 26卷
关键词：
chronic obstructive pulmonary disease; formoterol; long-acting beta; agonist; maintenance therapy; nebulization; tiotropium;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1024 / 1034
页数：10
相关论文
共 50 条
  • [41] Management of Chronic Obstructive Pulmonary Disease with Tiotropium Bromide
    Mamary, A. James
    Criner, Gerard J.
    CLINICAL MEDICINE INSIGHTS-THERAPEUTICS, 2010, 2 : 271 - 284
  • [42] Chronic obstructive pulmonary disease: the evidence for use of tiotropium
    Burns, G
    Bianchi, S
    BRITISH JOURNAL OF HOSPITAL MEDICINE, 2006, 67 (02) : 85 - 91
  • [43] Tiotropium versus placebo for chronic obstructive pulmonary disease
    Karner, Charlotta
    Chong, Jimmy
    Poole, Phillippa
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (07):
  • [44] Cost Effectiveness of Budesonide/Formoterol Added to Tiotropium Bromide versus Placebo Added to Tiotropium Bromide in Patients with Chronic Obstructive Pulmonary Disease: Australian, Canadian and Swedish Healthcare Perspectives (vol 29, pg 403, 2011)
    Mittmann, Nicole
    PHARMACOECONOMICS, 2011, 29 (05) : 414 - 414
  • [45] Specific role of combination aclidinium: formoterol in the treatment of chronic obstructive pulmonary disease
    Matera, Maria Gabriella
    Sanduzzi, Alessandro
    Cazzola, Mario
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 73 - 79
  • [46] Efficacy of salmeterol and formoterol combination treatment in mice with chronic obstructive pulmonary disease
    Wang, Zhiyuan
    Wang, Chunyan
    Yang, Xiaoli
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2018, 15 (02) : 1538 - 1545
  • [47] Optimization of Nebulized Budesonide in the Treatment of Acute Exacerbation of Chronic Obstructive Pulmonary Disease
    Zhang, Rui
    Zhu, Jiechen
    Liu, Yanan
    Li, Yuanqin
    Liu, Wenjing
    Zhang, Maowei
    Chen, Bi
    Zhu, Shuyang
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2020, 15 : 409 - 415
  • [48] Pharmacokinetics and Pharmacodynamics of Tiotropium Solution and Tiotropium Powder in Chronic Obstructive Pulmonary Disease
    Hohlfeld, J. M.
    Sharma, A.
    van Noord, J. A.
    Cornelissen, P. J. G.
    Derom, E.
    Towse, L.
    Peterkin, V.
    Disse, B.
    JOURNAL OF CLINICAL PHARMACOLOGY, 2014, 54 (04): : 405 - 414
  • [49] Effect of Triple Therapy with Budesonide-Formoterol-Tiotropium Versus Placebo-Tiotropium on Sleep Quality in Patients with Chronic Obstructive Pulmonary Disease
    Krachman, Samuel L.
    Vega, Maria Elena
    Yu, Daohai
    Demidovich, Joseph
    Patel, Harsh
    Jaffe, Frederic
    Soler, Xavier
    Shariff, Tahseen
    D'Alonzo, Gilbert E.
    Chatila, Wissam
    Weaver, Sheila
    Daraz, Yasmin
    Cohen, Sydney
    Criner, Gerard J.
    CHRONIC OBSTRUCTIVE PULMONARY DISEASES-JOURNAL OF THE COPD FOUNDATION, 2021, 8 (02): : 219 - 229
  • [50] Aclidinium bromide and formoterol fumarate for the maintenance treatment of chronic obstructive pulmonary disease
    Haley, Ryan
    Gupta, Nita
    Sethi, Sanjay
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2020, 13 (02) : 103 - 113
12345